Articles

Intracameral phenylephrine is a straightforward and effective way to prevent the effects of floppy iris syndrome in patients taking systemic tamsulosin and undergoing cataract surgery.

The results of a questionnaire sent out to consultant ophthalmologists in the UK, has discovered that there is no one strategy in place for the management of glaucoma in pregnant women.

A new digital ophthalmoscope could provide optometrists with the ability to email detailed eye maps of patients to specialist eye doctors.

Bausch & Lomb is voluntarily recalling nine production lots of ReNu MultiPlus Multi-Purpose Solution.

The majority of patients with diabetic macular oedema (DME) who are given an injection of intravitreal triamcinolone (IVTA), will go on to develop cataract.

Daily oral administration of ruboxistaurin (RBX) may delay progression of diabetic macular oedema (DME) to a sight-threatening stage.

Anterior chamber intraocular lenses (IOLs) last twice as long as posterior chamber IOLs, before they need to be replaced.

The last few months have been particularly busy ones for me; we've reached April already and I really don't know where the first three months of 2007 have disappeared to. However, one thing that always gets me through particularly busy or stressful times is the great sense of achievement I feel when something is completed and also, a holiday, which I shall be spending this year with my husband in beautiful Italy.

Eyemaginations has been selected by Carl Zeiss Meditec to release two new patient education animations.

The annual cumulative cell loss in eyes implanted with toric iris-fixated phakic intraocular lenses (IOLs) is two to three times greater than in normal eyes without surgery, according to the results of a study published in the February issue of the Journal of Refractive Surgery.

A Phase I clinical study of Athenagen's topical eye drop therapy for wet age-related macular degeneration (AMD), ATG3, has found it to be safe and well tolerated.

Iridex has been granted a summary judgement, by the US District Court for the Eastern District of Missouri, on its against Synergetics.

Lux Biosciences has begun treating patients in a pivotal clinical trial programme of LX211.

Preliminary results from a Phase I trial of TargeGen's TG100801 eye drop for macular degeneration, has found it to be well tolerated in humans.

Nitric oxide-donating derivatives of latanoprost for the treatment of glaucoma have been shown to successfully lower intraocular pressure (IOP) in preclinical studies.

Tacrolimus is relatively safe and effective in reducing rejection and prolonging graft survival in subjects with high-risk keratoplasty.

Staar Surgical has revealed that its Visian toric implantable collamer lens (TICL) is unlikely to receive FDA approval in 2007.

SR Pharma has launched a Phase I clinical trial of RTP-801i.

A Phase I clinical study of Athenagen's topical eye drop therapy for wet age-related macular degeneration (AMD), ATG3, has found it to be safe and well tolerated.

Results of a Phase III trial of the once-daily formulation of Xibrom (ISTA Pharmaceuticals) has found it to be both safe and efficacious.

The 1st of March was declared "ORBIS Day" in New York City, USA, by Mayor Michael R. Bloomberg.

Eyemaginations has been selected by Carl Zeiss Meditec to release two new patient education animations.

Microincision cataract surgery (MICS) and phacoemulsification result in similar visual outcomes and early endothelial cell loss.

Fear of going blind may be more likely to motivate teenagers to stop smoking than the fear of heart or lung disease.

For most patients with choroidal neovascularization (CNV) resulting from age-related macular degeneration (AMD), triple therapy offers significant and sustained visual improvement after just one cycle of treatment.

Senior doctors have accused the independent sector treatment centre (ISTC) scheme for NHS cataract services of being an expensive over-reaction to the need to increase the rate of cataract surgery in the UK.

Glaucoma medication timolol exerts a direct antioxidant effect, protecting human endothelial cells from oxidative stress.

The annual cumulative cell loss in eyes implanted with toric iris-fixated phakic intraocular lenses (IOLs) is two to three times greater than in normal eyes without surgery.

IntraLase has entered into an agreement with Escalon Medical to settle all outstanding disputes and litigation between the parties.

GDx variable cornea compensation with scanning laser polarimetry (SLP-VCC), Heidelberg retina tomography (HRT) confocal scanning laser ophthalmoscopy (CSLO) and stereoscopic optic nerve head (ONH) photographs may all be useful in assisting clinicians to diagnose glaucoma.